Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyThu, 02 May 2024 16:12:50 +0200Wed, 20 Mar 2024 17:40:00 +0100Human medicines European public assessment report (EPAR): Tagrisso, osimertinib, Date of authorisation: 01/02/2016, Revision: 20, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/tagrissoHuman medicines European public assessment report (EPAR): Tagrisso, osimertinib, Date of authorisation: 01/02/2016, Revision: 20, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/tagrissoWed, 20 Mar 2024 17:40:00 +0100Human medicineTagrisso-H-C-4124-II-0009-G : EPAR - Assessment Report - Variationhttps://www.ema.europa.eu/system/files/documents/variation-report/wc500227937_en.pdfTagrisso-H-C-4124-II-0009-G : EPAR - Assessment Report - Variationhttps://www.ema.europa.eu/system/files/documents/variation-report/wc500227937_en.pdfTue, 16 May 2017 02:00:00 +0200Human medicine